RHYTHM PHARMACEUTICALS, INC. (RYTM) › Operating IncomeRHYTHM PHARMACEUTICALS, INC. (RYTM) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2015: -$10.57M2016: -$25.91M2017: -$32.41M2018: -$78.42M2019: -$146.00M2020: -$136.57M2021: -$170.06M2022: -$179.16M2023: -$184.36M2024: -$265.50M2025: -$192.02M-$192.02M2015Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$192.02M+27.7%2024-$265.50M-44.0%2023-$184.36M-2.9%2022-$179.16M-5.3%2021-$170.06M-24.5%2020-$136.57M+6.5%2019-$146.00M-86.2%2018-$78.42M-141.9%2017-$32.41M-25.1%2016-$25.91M-145.0%2015-$10.57M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share